Desvenlafaxine · larger labeled portfolio than Atomoxetine
SPL labels Atomoxetine + Desvenlafaxine as minor; Atomoxetine 14 / Desvenlafaxine 13 in that band.
Mechanism on file: Desvenlafaxine does not have a significant impact on the levels of atomoxetine in your body.
FDA SPL severity: Minor
Atomoxetine + Desvenlafaxine · SPL mechanism field
Desvenlafaxine does not have a significant impact on the levels of atomoxetine in your body.
Minor band excerpt · Atomoxetine with Desvenlafaxine
Examples desipramine, atomoxetine, dextromethorphan, metoprolol, nebivolol, perphenazine, tolterodine 7.2 Drugs Having No Clinically Important Interactions with PRISTIQ Based on pharmacokinetic studies, no dosage adjustment is required for drugs that are mainly metabolized by CYP3A4 (e.g., midazolam), or for drugs that are metabolized by both CYP2D6 and CYP3A4 (e.g., tamoxifen, aripiprazole), when administered concomitantly with PRISTIQ [see Clinical Pharmacology (12.3) ].
Atomoxetine · 14 minor + 15 total pairs
- Celecoxib minor
- Desipramine minor
- Diazepam minor
- Dobutamine minor
Desvenlafaxine · 19 SPL pairs (broader portfolio than Atomoxetine)
- Aripiprazole minor
- Buspirone minor
- Desipramine minor
- Dextromethorphan minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.